Group DP [25(OH)D ≥ 50 nmol/L, Pi≥3.5 mg/dL], (n = 87) | Group D [25(OH)D ≥ 50 nmol/L, Pi < 3.5 mg/dL] (n = 54) | Group P [25(OH)D < 50 nmol/L, Pi≥3.5 mg/dL] (n = 59) | Group 0 [25(OH)D < 50 nmol/L, Pi < 3.5 mg/dL] (n = 55) | p-value, for the trend | |
---|---|---|---|---|---|
BMI at baseline (kg/m2) | 37.8 (36.0–42.1) | 37.3 (35.9–40.8) | 38.9 (36.4–45.2) | 38.0 (35.9–40.5) | .222** |
BMI in the final visit (kg/m2) | 36.0 (34.3–38.8) | 35.9 (34.8–38.6) | 37.8 (35.7 (41.9) | 37.4 (35.6–40.4) | .002** |
Weight loss (%), (95% Confidence interval) | 6.3 (3.1–9.6) | 4.1 (0.4–7.7) | 3.8 (0.3–7.3) | Reference | a,b*** |
Fat mass loss (%), (95% Confidence interval) | 11.1 (5.2–17.0) | 8.1 (1.5–14.6) | 7.3 (1.0–13.7) | Reference | a,b*** |
Weight loss ≥10%, (n = 61)* | 26 (29.9) | 12 (22.2) | 12 (20.3) | 6 (10.9) | <.001**** |
Weight loss 5–9.9%, (n = 75)* | 28 (32.2) | 13 (24.1) | 13 (22.0) | 11 (20.0) | |
Weight loss < 5%, (n = 87) * | 23 (26.4) | 17 (31.5) | 21 (35.6) | 15 (27.3) | |
Weight gain (n = 62)* | 10 (11.5) | 12 (22.2) | 13 (22.0) | 23 (41.8) |